Related references
Note: Only part of the references are listed.Long-term safety of pegloticase in chronic gout refractory to conventional treatment
Michael A. Becker et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Anna Koettgen et al.
NATURE GENETICS (2013)
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
Essack Mitha et al.
RHEUMATOLOGY (2013)
Treatment of Chronic Gouty Arthritis: It Is Not Just About Urate-Lowering Therapy
Naomi Schlesinger
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography
N. Dalbeth et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Role of the Urate Transporter SLC2A9 Gene in Susceptibility to Gout in New Zealand Maori, Pacific Island, and Caucasian Case-Control Sample Sets
Jade E. Hollis-Moffatt et al.
ARTHRITIS AND RHEUMATISM (2009)
Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile
H. K. Choi et al.
RHEUMATOLOGY (2008)